Induced Mesenchymal Stem Cells: An Emerging Source for Regenerative Medicine Applications

Area of Science:

• Regenerative Medicine
• Stem Cell Biology
• Cell Therapy

Background:

• Conventional treatments often fail to address disease root causes, driving interest in regenerative medicine.
• Mesenchymal stem cells (MSCs) are widely used in regenerative medicine due to tissue repair capabilities.
• Limitations of adult MSCs include scarcity, heterogeneity, limited proliferation, and senescence, hindering clinical applications.

Purpose of the Study:

• To review the characteristics, regenerative potential, and limitations of MSCs for regenerative medicine.
• To detail methods for generating induced MSCs (iMSCs) from induced pluripotent stem cells (iPSCs).
• To explore iMSC applications in disease modeling, drug discovery, and regenerative medicine.

Main Methods:

• Review of existing literature on MSCs and iMSCs.
• Detailed discussion of iMSC generation protocols from iPSCs.
• Exploration of molecular characterization criteria for iMSCs.

Main Results:

• Adult MSCs face limitations in number, heterogeneity, proliferation, and senescence.
• Induced MSCs (iMSCs) derived from iPSCs offer patient-specific, readily available cells with superior regenerative potential.
• iMSCs show promise for disease modeling, drug discovery, and clinical regenerative medicine applications.

Conclusions:

• iMSCs present a viable solution to overcome the limitations of primary MSCs in regenerative medicine.
• The patient-specific nature and enhanced potential of iMSCs make them valuable for research and therapeutic development.
• Further exploration of iMSC applications is crucial for advancing regenerative medicine strategies.